| A 2-part Phase 1/2 Open-label Trial on ODM-212 (NCT07563738) | Orion Corporation, Orion Pharma | 2026-03-27 |
| A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours (NCT06725758) | Orion Corporation, Orion Pharma | 2023-10-26 |
| Efficacy and Tolerability of Tasipimidine in Sleepless Patients (NCT06956495) | Orion Corporation, Orion Pharma | 2023-08-20 |
| Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal (NCT05811039) | Orion Corporation, Orion Pharma | 2023-05-17 |
| Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product (NCT05288075) | Orion Corporation, Orion Pharma | 2022-02-28 |
| Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler (NCT05246046) | Orion Corporation, Orion Pharma | 2022-02-16 |
| Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (NCT05084222) | Orion Corporation, Orion Pharma | 2021-11-11 |
| Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With Asthma (NCT04869384) | Orion Corporation, Orion Pharma | 2021-06-23 |
| Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler (NCT04856098) | Orion Corporation, Orion Pharma | 2021-05-07 |
| Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler® (NCT04850144) | Orion Corporation, Orion Pharma | 2021-04-26 |
| Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway (NCT04663386) | Orion Corporation, Orion Pharma | 2020-12-10 |
| Digital Therapeutics (DTx) for Pain: Pilot Study of a Virtual Reality Software for Chronic Pain (NCT04225884) | Orion Corporation, Orion Pharma | 2020-02-04 |
| Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHaler (NCT04147572) | Orion Corporation, Orion Pharma | 2019-11-01 |
| Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension (NCT03948178) | Orion Corporation, Orion Pharma | 2019-06-26 |
| Effect of Charcoal on Gastrointestinal Absorption of Tiotropium (NCT03945344) | Orion Corporation, Orion Pharma | 2019-05-27 |
| Safety and Pharmacokinetics of ODM-209 (NCT03878823) | Orion Corporation, Orion Pharma | 2019-04-17 |
| Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax (NCT03802903) | Orion Corporation, Orion Pharma | 2019-03-12 |
| Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD (NCT03755544) | Orion Corporation, Orion Pharma | 2019-01-16 |
| Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS (NCT03505021) | Orion Corporation, Orion Pharma | 2018-06-21 |
| Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer (NCT03436485) | Orion Corporation, Orion Pharma | 2018-03-19 |